Emerson Electric (EMR) JPMorgan Industrials Conference 2026 summary
Event summary combining transcript, slides, and related documents.
JPMorgan Industrials Conference 2026 summary
17 Mar, 2026Global business environment and regional impacts
Middle East and Africa account for 9% of sales, with 1,500 employees in the region; operational continuity and employee safety are top priorities amid recent disruptions.
Logistics in the Middle East remain challenging, but operations in Dubai and Saudi Arabia are running; impact is manageable if disruptions resolve soon.
Higher oil prices could benefit the region but pose modeling challenges for Europe and China; expectation is for transitory effects with normalization in the second half of the year.
Business performance and growth outlook
Q1 saw strong order growth: overall up 9%, North America up 18%, India up 20%+, Asia up 13%, and Middle East activity strong.
Project pipeline stands at $11 billion, with $6.4 billion in growth verticals (life sciences, aerospace/defense, semi, LNG, power); MRO business remains strong.
Weakness persists in Europe and China, especially in automotive and chemicals, but North America, Middle East, India, and test & measurement (T&M) are robust.
Power and Ovation orders have a two-year lead time, translating to revenue in 2026–2028.
LNG and life sciences verticals show continued momentum, with significant U.S. LNG capacity expansion opportunities.
Segment and product trends
T&M business is strong, led by aerospace and semiconductors; automotive testing remains muted, especially in Europe.
Book-to-bill ratio in T&M is above 1, supporting growth into 2027.
Discrete business remains sluggish, with China and Europe still muted.
Latest events from Emerson Electric
- AI-driven software growth and robust U.S. demand fuel strong performance and future outlook.EMR
Citi's Global Industrial Tech & Mobility Conference 202618 Feb 2026 - Strong order growth, innovation, and high margins drive a positive outlook and investor confidence.EMR
Barclays 43rd Annual Industrial Select Conference17 Feb 2026 - Q1 2026 saw 4% sales growth, 6% EPS growth, and raised guidance, driven by automation demand.EMR
Q1 20264 Feb 2026 - Targeting $21B sales, 30% EBITA margin, $8.00 EPS, and $10B shareholder returns by 2028.EMR
Investor Update3 Feb 2026 - Director elections and key proposals passed; board declassification did not meet approval threshold.EMR
AGM 20263 Feb 2026 - Q3 sales and adjusted EPS up 11%, Copeland exit boosts debt reduction and guidance raised.EMR
Q3 20242 Feb 2026 - Record FY24 growth, portfolio actions, and $2B buyback set up strong 2025 outlook.EMR
Q4 202416 Jan 2026 - Record margins, 13% EPS growth, and robust cash flow with AspenTech deal pending.EMR
Q1 20259 Jan 2026 - Strong financials, board declassification vote, and ESG progress highlight this year's proxy.EMR
Proxy Filing12 Dec 2025